Previous research has identified molecular biomarkers such as CA15-3 (cancer antigen 15-3), uPA (Urokinase-type plasminogen activator), and HER2 (Human Epidermal Growth Factor Receptor 2) as being associated with breast cancer. This evidence concerns the gene PLAU and breast carcinoma.